The iPad vs. the Surface Pro. iOS vs. Windows 8. Apple vs. Microsoft. Have these two tech heavyweights elicited an internal debate within pharma companies over which device is better for their sales teams or is the choice a foregone conclusion? After all, pharma has already heavily adopted the iPad and they are not alone. According to preliminary data from the International Data Corporation (IDC) Worldwide Quarterly Tablet Tracker, worldwide tablet shipments have increased 142.4% year over year in the first quarter of 2013 with Apple capturing 39.6% of the market share of tablet operating systems compared to Microsoft’s 3.3%—however Android comes out on top with 56.5%. Of course, Microsoft has only recently ramped up its presence in this market with its release of the Surface RT and Surface Pro in the beginning of this year and we wouldn’t be having this discussion if pharma didn’t have some reservations over the iPad.

See on www.pm360online.com